1. Merger of Rotman's and their $35m in revenues (per 10q) 2. No Convertible Debt on books (per PR) 3. Massive Insider buying (per Form 4 filings) 4. Recent Institutional Investment of $200k at .15 (per PR) 5. New European Patents (per PR) 6. Possible buyback of shares by the company (per 10q) 7. Possible EMA share buyback (pending judge's response to lawsuit)
Buy now and enjoy massive profits in the near term!
#VYST #lifechanger
LOOKS LIKE ALL THIS IS COMING TRUE, AND MORE...
#VYST is definitely the needle in the haystack in the OTC sewer.
Furthermore, where do you find a fully audited company in the OTC?
Answer: YOU DON'T...Except VYST.
This IS the Golden Unicorn~
Looking forward to a very interesting and profitable summer. Long on VYST